StockData
Serina Therapeutics, Inc. logo

Serina Therapeutics, Inc. (SER) stock

SERNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.42+0.03 (+2.16%)

Close on Nov 16, 2026Market cap $36.07MP/E –Yield –

Serina Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Serina Therapeutics's pe ratio was 12.2× on Apr 30, 2024.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Apr 30, 202412.2×+2.5
2023Dec 29, 20239.6×–

More Serina Therapeutics figures

See a number that looks wrong?